Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-08-20
1998-03-17
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514626, 514885, A61K 3142, A61K 3116
Patent
active
057287210
ABSTRACT:
The use of compound 1 and/or 2 of the formulae ##STR1## and of physiologically tolerable salts of compound 2 for the treatment of rejection reactions of the organ recipient to the transplanted organ is described.
REFERENCES:
patent: 4061767 (1977-12-01), Ertel et al.
patent: 4284786 (1981-08-01), Kammerer et al.
patent: 4965276 (1990-10-01), Bartlett et al.
C.C.A. Kuchle et al., "Prevention of Kidney and Skin Graft Rejection Rates by Leflunomide, a New Immunolodulaitng Agent," Transplantation Proceedings, vol. 23, No. 1 (Feb. 1991), pp. 1083-1086.
D.B.J. Herrmann et al., "Drugs in Autoimmune Diseases," Klinische Wochenschrift, vol. 68 (Suppl. XXI) (1990), pp. 15-25.
K. Ulrichs et al., "Suppression of Natural Xenophile Antibodies with the Novel Immunomodulating Drug Leflunomide," Transplantation Proceedings, vol. 24, No. 2 (Apr. 1992), pp. 718-719.
R.R. Bartlett, et al., "Leflunomide (HWA 486), a Novel Immunomodulating Compound for the Treatment of Autoimmune Disorders and Reactions Leading to Transplantation Rejection," Agents and Actions, vol. 32, Nos. 1/2 (1991), pp. 10-21.
Xenogeneic Transplantations, Auchincloss, Jr., Transplantation, 46(1):1-20 (1989).
Ivan M. Roitt, Jonathan Brostoff and David K. Male, "Immunology", ch. 24 Transplantation and Rejection, pp. 24.1 to 24.9, Gower Medical Publishing (1985).
Cintins Marianne M.
Hoechst Aktiengesellschaft
Moezie M.
LandOfFree
Pharmaceuticals for the treatment of rejection reactions in orga does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceuticals for the treatment of rejection reactions in orga, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceuticals for the treatment of rejection reactions in orga will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-958030